PTGS2 Skin Disorders Carnosine Compound Treatment Method
Summary
USPTO published patent application US20260096978A1 disclosing a method for preventing, mitigating, or treating PTGS2-induced skin disorders using carnosine compounds of formula (I) applied to human skin. The application, filed November 14, 2022, names five inventors and covers cosmetic and dermatological formulations.
What changed
USPTO published patent application US20260096978A1 for a method using carnosine compounds (formula I, where R1=H/CH3 and R2=H/COOH) to prevent, mitigate, or treat PTGS2-induced skin disorders and related dysfunctions. The application covers non-therapeutic topical applications to human skin.
Pharmaceutical and cosmetic companies developing skin disorder treatments should monitor this application for potential licensing or design-around considerations. The broad claims covering PTGS2-induced disorders and carnosine derivatives may impact freedom-to-operate analyses for dermatological product developers.
What to do next
- Monitor for patent prosecution updates
- Review freedom-to-operate for skin disorder treatments
- Evaluate potential licensing opportunities
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS
Application US20260096978A1 Kind: A1 Apr 09, 2026
Inventors
Dominik STUHLMANN, Maria REICHENBACH, Paul SLAVASHEVICH, Christina GIRARDI, Michele MASSIRONI
Abstract
Suggested is a non-therapeutic method for preventing, mitigating or treating PTGS2-induced disorders of human skin and related dysfunctions, comprising or consisting of the following step: —applying a working amount of a carnosine compound according to formula (I) in which R1 stands for H or CH3 and R2 for H or COOH, to human skin
CPC Classifications
A61K 8/64 A61K 38/05 A61P 17/16 A61Q 17/04 A61Q 19/08
Filing Date
2022-11-14
Application No.
19110636
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.